Screener
Arcutis Biotherapeutics, Inc. ARQT Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
FAQ
- What is Arcutis Biotherapeutics, Inc.'s accrued manufacturing costs?
- Arcutis Biotherapeutics, Inc. (ARQT) reported accrued manufacturing costs of $15.51M in Q2 2026.
- How has Arcutis Biotherapeutics, Inc.'s accrued manufacturing costs changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s accrued manufacturing costs increased by 25.9% year-over-year, from $12.32M to $15.51M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s accrued manufacturing costs?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s accrued manufacturing costs has grown at a 35.9% compound annual growth rate (CAGR), from $4.43M to $20.53M.
- What does accrued manufacturing costs mean?
- Accrued liabilities related to manufacturing and production activities.
Ask your AI about Arcutis Biotherapeutics, Inc.'s accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude